4
Changes in Ownership
Edgewise Therapeutics, Inc. Filed Acc 0001562180-25-005233
Director acquired 858 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fox Jonathan C Director | 2025-07-01 | Grant or award | +858 | 12,274 | D: show line 1 in the form |
Loading xslF345X05/primarydocument.xml…